Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Invivo Therapeutics Holdings Corp. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 1 | 13 | +12 |
| Shares | 1 | 63.0K | +63.0K (+6,302,400.0%) |
| Value | $1.00K | $257.0K | +$256.0K (+25,600.0%) |
New holders (12)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 34,710 | $141.0K | 0.00% |
| Citadel Advisors LLC | 15,127 | $62.0K | 0.00% |
| Geode Capital Management, LLC | 11,046 | $44.0K | 0.00% |
| Morgan Stanley | 1,154 | $5.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 896 | $4.00K | 0.00% |
| Bank of America Corp | 1 | $0 | 0.00% |
| Wells Fargo & Company | 9 | $0 | 0.00% |
| Royal Bank of Canada | 70 | $0 | 0.00% |
| UBS Group AG | 1 | $0 | 0.00% |
| Sugarloaf Wealth Management, LLC | 1 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 7 | $0 | 0.00% |
| Coastal Capital Group, Inc. | 2 | $0 | 0.00% |
Sold out (0)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q1 2022 and filed for Q2 2022 without it.
None.